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Background: Quality of life (QoL) is affected in patients with dementia, but it is not clear whether it is already
disturbed in more initial phases of cognitive decline, like Mild Cognitive Impairment (MCI).
Aim: Compare the QoL in MCI patients with controls without cognitive impairment, and ascertain whether there
are differences in the reports of QoL made by the subjects and by their informants.
Methods: Two hundred participants were enrolled, divided into MCI patients (n¼ 50), MCI informants (n¼ 50),
recruited from a memory clinic and a dementia outpatient clinic, and controls (n¼ 50) and controls
informants (n¼ 50), recruited in a family practice clinic. QoL was assessed with the QoL in Alzheimer disease
(QOL-AD) scale.
Results: The total scores of the QOL-AD questionnaire were 32.1� 6.9 for MCI patients self-report, 27.2� 6.7
for MCI patients in the opinion of their informants, 35.3� 4.9 for controls self-report and 35.6� 4.9 for controls
in the opinion of their informants. MCI patients had lower QOL-AD scores than controls. The QoL reported by
patients with MCI was more favorable than the opinion of their informants.
Conclusion: The QoL is affected at early stages of cognitive decline. The QoL reported by patients with MCI is
better than the opinion of their informants, similarly to what is known in Alzheimer’s disease patients. QoL
appears to be an important domain to be evaluated in aging studies.
Keywords: QOL-AD; MCI; Alzheimer’s disease; caregiver-report; self-report
Introduction
Quality of Life (QoL) is recognized as an increasingly
important healthcare topic to ascertain the real impact
of disease and treatment in human life, particularly in
chronic disorders (Muldoon, Barger, Flory, &
Manuck, 1998). The World Health Organization
(1995) defined QoL as the individual’s perception of
their position in life in the context of culture and value
system in which they live, and in relationship to their
goals, expectations, and standards. This definition
assumes that individuals have the intellectual capacity
to make complex subjective judgments about their
lives. Many questions have been raised about the
ability of persons with dementia to make such judg-
ments and about the point at which they become
unable to do so. Assessing QoL in cognitively impaired
older adults certainly poses unique challenges because
QoL is a complex process that involves many cognitive
abilities such as attention, memory, language, and
abstract thinking which are likely affected in these
patients (Logsdon, Gibbons, McCurry, & Teri, 2002).
Nevertheless, QoL has been identified as an important
domain for dementia assessment (Lawton, 1994).
Furthermore, QoL is an indicator of the overall
impact of interventions for individuals with dementia,
and improving QOL has been advanced as a primary
goal of dementia treatment (Logsdon, McCurry, &
Teri, 2007).
QoL was indeed found to be affected in patients
with dementia, more so in the opinion of the caregivers
than of the patients themselves (Conde-Sala, Garre-
Olmo, Turro´-Garriga, Lo´pez-Pousa, & Vilalta-Franch,
2009; Hurt et al., 2008; Ready, Ott, & Grace, 2004;
Thorgrimsen et al., 2003; Vogel, Mortensen,
Hasselbalch, Andersen, & Waldemar, 2006).
However, more pronounced cognitive deficits or
greater limitations in daily activities are not necessarily
reflected in lower QoL in patients with dementia
(Banerjee et al., 2009). It is controversial whether QoL
is already disturbed in more initial phases of cognitive
decline, like Mild Cognitive Impairment (MCI), a
clinical entity now accepted in both clinical practice
and research that entails a high risk of progression to
dementia. Some researchers found that QoL is not
affected in MCI patients (Missotten et al., 2008; Ready
et al., 2004) while other detected that some aspects of
QoL are altered (Muangpaisan, Assantachai,
Intalapaporn, & Pisansalakij, 2008).
Several instruments have been validated to evaluate
QoL in patients with cognitive decline and dementia.
In the present study, we used the QOL-AD scale, a
short, self-characterization instrument that can be
*Corresponding author. Email: mendonca@fm.ul.pt
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completed by patients unless severely demented and is
able to provide both the caregivers’ and the patients’
point of view (Logsdon et al., 2002). The objective of
the present work was to ascertain whether patients
with MCI have a decrease in the QoL as compared to
subjects without cognitive impairment. Additionally,
we aimed to compare the reports of QoL made by the
subjects and by their informants, both in MCI patients
and in subjects without cognitive impairment.
Materials and methods
Participants
Participants were patients with MCI, and their infor-
mants (MCI-informants), attending a memory clinic
and a dementia outpatient clinic. Controls and their
informants (controls-informants) were recruited in a
family medicine outpatient clinic. The study was
approved by the Ethics Committee of Hospital de
Santa Maria. Before any procedure, participants gave
written informed consent.
Inclusion criteria for MCI group were based on
European Consortium on Alzheimer’s Disease (Portet
et al., 2006). For reasons of sample homogeneity, only
patients with the amnestic type of MCI (aMCI) were
recruited:
(1) Cognitive complains and cognitive decline
during the last year, reported by the patient
and/or family.
(2) Objective memory impairment, as defined by a
low score in immediate free recall of story A
from logical memory (LM) subtest of Wechsler
Memory Scale (see below).
(3) Maintained activities of daily living or slight
impairment in instrumental activities of daily
living (IADL), as defined by no more than one
item of IADL changed (see below).
(4) Absence of dementia, according to DSM-IV,
and normal Mini Mental State Examination
(MMSE) scores (see below).
(5) Age 50 years.
Inclusion criteria for MCI-informants, controls and
controls-informants:
(1) Absence of cognitive complains.
(2) Normal score in immediate free recall of story
A from LM subtest of Wechsler Memory Scale
(see below).
(3) Maintained activities of daily living as defined
by IADL (no item of IADL changed, see
below).
(4) Absence of dementia, according to DSM-IV,
and normal MMSE scores (see below).
(5) Age 50 years for controls (age was not a
criterion for informants).
Exclusion criteria for all groups:
(1) History of alcohol abuse or recurrent substance
abuse or dependence.
(2) Other neurological, psychiatric or medical dis-
orders that might induce cognitive deficits.
(3) Major depressive episode according to DSM
IV, or severe depressive symptoms as reflected
by a score in the 15 item Geriatric Depression
Scale (GDS15)4 10 (see below).
(4) Education (schooling years) less than four
years.
Procedures
A separate interview with patients or controls and
their informants was conducted. The informants were
close relatives who knew the patient/control well.
Demographic data (age, sex, education, marital
status, and occupation) and clinical data were collected
during the interview for all participants.
MCI patients underwent a standard protocol with
clinical history, neurological examination, laboratorial
evaluation, and brain imaging (CT scan or MRI scan)
(Knopman et al., 2001), and a detailed neuropsycho-
logical evaluation with the Battery of Lisbon for
Evaluation of Dementia (Garcia, 1984).
All participants were submitted to the Portuguese
versions (de Mendonc¸a & Guerreiro, 2008) of the
following instruments:
(1) MMSE (Folstein, Folstein, & McHugh, 1975),
MMSE is widely used for brief evaluation of
the mental state and screening of dementia. The
normative cut-off values for the Portuguese
population adjusted to education were used
(Guerreiro, Silva, & Botelho, 1994). Subjects
should score above 22 if they had 11 years of
education, or above 27 if they had411 years of
education.
(2) LM subtest from the Wechsler Memory Scale
(Wechsler, 1969), which is included in the
Battery of Lisbon for the Evaluation of
Dementia (Garcia, 1984). Memory was consid-
ered impaired when the subjects scored on
immediate free recall of story A of the test at
least 1.5 standard deviation (SD) below the
normative value for age and education.
(3) IADL (Lawton & Brody, 1969). The IADL
score reflects the number of impaired activities
and ranges from 0 (no impairment) to 8
(changes in all items). Items were classified as
not applicable if the activity had never been
done before or if the subject stopped doing it
for reasons other than cognitive difficulty.
Activities of daily living were considered pre-
served if no item from the IADL scale suffered
any change, or mildly affected if only one item
from the IADL scale was altered (Pantoni
et al., 2005).
(4) GDS (Yesavage et al., 1983). The GDS is a self-
report depression assessment scale used speci-
fically to evaluate depression in the elderly. The
15 item version was used for this study.
H. Bárrios
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(5) Satisfaction with Life Scale (SWLS; Diener,
Emmons, Larsen, & Griffin, 1985). This scale
assesses global life satisfaction reflecting sub-
jective well-being.
(6) QOL-AD scale (Logsdon et al., 2002). The
QOL-AD scale is a short, self-characterization
instrument that can be completed by patients
unless severely demented. It comprises 13 items
within five domains: ‘perceived QoL’, ‘behav-
ioral competence’, ‘psychological status’,
‘interpersonal environment’ and ‘physical func-
tioning’. QOL-AD uses simple and straightfor-
ward language. Responses are structured in a
four-choice format for all the items and the total
score is obtained by adding the score of
individual items. The total scores range from
13 to 52 and lower points are associated with
worse QoL. One of the main advantages of
QOL-AD is that it can provide both caregiver
and patient point of view. Each individual
completed the scale alone, as instructions were
read. For those participants with reading diffi-
culties the interviewer would circle the answer.
(7) Charlson, Pompei, Ales, and McKenzie (1987)
Index. This index measures the presence of 22
pre-set conditions, with a relative weight for
each pathology. Increasing scores indicate
higher mortality risk. In the original study, one
yearmortality rates for the different scores were:
‘0’, 8%; ‘1–2’, 26%; ‘3–4’, 52%; ‘�5’, 85%.
Of the 214 participants initially evaluated, 14 were
excluded from the study for the following reasons:
severe depression at the time of the evaluation (n¼ 12)
and lack of collaboration from the accompanying
relative (n¼ 2).
Statistical analysis
Statistical Analysis was performed using Statistical
Package for the Social Sciences (SPSS 19.0. SPSS INC:
IBM). The significance level used for all analysis was
p5 0.05.
Comparison of demographic characteristics among
the four groups was made with one-way ANOVA for
numerical variables and the chi-square test for cate-
gorical variables. Comparison of Charlson index
between MCI and control subjects was made with the
Student’s t test for independent variables.
Differences in MMSE, LM, GDS, and SWLS
among the four groups were analyzed with one-way
ANOVA, followed by post-hoc Tukey’s test when
appropriate. Since for both MCI patients and controls,
two QOL-AD reports were available (the own report
and the informant’s report), analysis of QOL-AD total
score was done with repeated measures ANOVA. The
within-subjects analysis compared the subjects’ own
report with the report of their informants. The
between-subjects analysis compared MCI patients
with controls.
Comparison of scores of individual QOL-AD items
was done with one-way ANOVA. Analysis of differ-
ences between MCI and control self-reports, and
between MCI self report and informant report, was
performed with the post-hoc Dunnett test (MCI self-
report was the reference group). Since, this was an
exploratory analysis, no correction for multiple com-
parisons was done.
Results
The study recruited 200 participants, divided into four
groups: MCI patients (n¼ 50), their informants (MCI-
informants, n¼ 50), controls (n¼ 50) and their infor-
mants (controls-informants, n¼ 50). There were no
statistical differences among the groups regarding
demographic variables (Table 1). MCI informants
were spouses (38), sons/daughters (8), sister/brother
(3) and sister-in-law (1). Controls informants were
spouses (45), sons/daughters (4), and sister-in-law (1).
Patients with MCI had a higher Charlson Index
(2.71� 0.94) than controls (2.08� 1.16, p¼ 0.03,
Student’s t test).
No statistically significant differences among the
groups were found in SWLS (Table 2). MCI patients
had lower scores in MMSE and LM and higher scores
in GDS compared to the other groups (Table 2).
The total scores of the QOL-AD questionnaire for
MCI patients, fulfilled by themselves (MCI) and by
their informants (MCI-informants), and for control
participants, fulfilled by themselves (controls) and by
their informants (controls-informants) are shown in
Table 2. The between-subjects analysis showed that
MCI patients had lower total QOL-AD scores than
Table 1. Study population demographic characteristics.
MCI MCI informants Control Control informants
N 25 25 26 26 p-value
Age (years) Mean (SD) 70.8 (6.2) 66.9 (9.5) 66.3 (10.8) 66.7 (9.9) 0.05*
Sex Men/women 22/28 21/29 25/25 23/27 0.87y
Education (years) Mean (SD) 10.7 (4.5) 11.1 (4.7) 9.0 (4.0) 9.7 (4.6) 0.08*
Notes: *One-way ANOVA.
yChi-square test.
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controls (p5 0.001). The within-subjects analysis
showed statistically significant differences between
the subject’s own report and their informant’s report
(p¼ 0.025). A significant interaction between the
report of QoL (own report vs. informant’s report)
and group (MCI vs. control) was found (p¼ 0.007;
repeated measures ANOVA; Table 2). In other words,
the significant difference between the subjects’ self
report and their informants’ report was driven by the
MCI patients.
Since MCI patients had a lower total QOL-AD
score than controls, we compared the individual QOL-
AD items in both groups. Significantly lower individ-
ual QOL-AD item scores were observed in seven of the
13 items in MCI patients (‘Energy’, ‘Humor’,
‘Memory’, ‘Marriage’, ‘Friends’, ‘Ability to do things
for fun’, and to do ‘House chores’) (Table 3).
Since the QoL-AD total score was higher in the
report of MCI patients than in the opinion of their
caregivers, we also compared in these patients the
individual QoL-AD item self-report scores and
informant scores. The MCI patients’ report was more
favorable than the opinion of their informants for the
items: ‘Family’, ‘Hability to do house chores’, ‘Self as a
whole’, and ‘Life as a whole’ (Table 3).
Discussion
The main finding of the present study was that the
QoL of MCI patients was decreased as compared to
controls without cognitive impairment. Whereas the
reports of controls and their informants were concor-
dant, the QoL reported by patients with MCI was
more favorable than the opinion of their informants.
It has been controversial whether the QoL is
affected in patients with MCI. Two previous studies
found no differences in QoL between MCI patients
and healthy controls, using different instruments to
evaluate QoL (Missotten et al., 2008; Ready et al.,
2004). The first study used the Dementia QoL Scale
(Brod, Stewart, Sands, & Walton, 1999), an instrument
Table 3. Scores in individual items of QOL-AD in MCI patients and control subjects, reported by themselves and by their
informants.
MCI
MCI
informants Control
Control
informants
Statistical
significance*
QOL-AD – physical health 2.22 (0.79) 1.98 (0.87) 2.44 (0.67) 2.38 (0.67)
QOL-AD – energy 1.94 (0.91) 1.90 (0.89) 2.40 (0.73) 2.54 (0.71) MCI5C
QOL-AD – mood 2.32 (0.79) 2.04 (0.90) 2.70 (0.68) 2.50 (0.65) MCI5C
QOL-AD – living situation 2.58 (0.70) 2.50 (0.79) 2.68 (0.59) 2.54 (0.65)
QOL-AD – memory 1.76 (0.89) 1.58 (0.73) 2.78 (0.98) 2.80 (0.93) MCI5C
QOL-AD – family 2.98 (0.82) 2.46 (1.07) 3.24 (0.75) 3.30 (0.68) MCI4MCI-I
QOL-AD – marriage 2.80 (0.78) 2.48 (0.93) 3.18 (0.60) 3.18 (0.60) MCI5C
QOL-AD – friends 2.52 (0.70) 2.40 (0.95) 2.94 (0.55) 3.00 (0.45) MCI5C
QOL-AD – self as a whole 2.32 (0.79) 1.96 (0.83) 2.54 (0.61) 2.62 (0.53) MCI4MCI-I
QOL-AD – ability to do chores
around the house
2.30 (0.87) 1.84 (0.91) 3.22 (0.65) 3.22 (0.79) MCI4MCI-I
MCI5C
QOL-AD – ability to do things for fun 2.02 (0.94) 2.00 (0.90) 2.66 (0.87) 2.56 (1.01) MCI5C
QOL-AD – money 2.40 (0.86) 2.24 (0.74) 2.06 (0.65) 2.04 (0.64)
QOL-AD – life as a whole 2.42 (0.84) 2.06 (0.82) 2.70 (0.58) 2.84 (0.47) MCI4MCI-I
Notes: Scores are mean (SD).
*Comparison of scores of individual QOL-AD items with one-way ANOVA. Analysis of differences between MCI and control
self-reports, and between MCI self- report and informant report, was performed with the post-hoc Dunnett test (MCI self-report
was the reference group).
Significant differences are shown (p5 0.05).
Table 2. Comparison of MMSE, LM, GDS, SWLS and QOL-AD scores in the study population.
MCI
MCI
informants Control
Control
informants p-value
Statistical
significance
MMSE Mean (SD) 26.3 (2.1) 29.3 (1.7) 29.6 (0.6) 29.7 (0.6) 50.001* MCI5MCI-I, C, C-I
LM Mean (SD) 7.5 (2.5) 17.5 (1.8) 16.8 (2.2) 17.6 (2.1) 50.001* MCI5MCI-I, C, C-I
GDS Mean (SD) 4.8 (2.5) 2.1 (1.9) 2.3 (2.2) 2.0 (2.1) 50.001* MCI4MCI-I, C, C-I
SWSL Mean (SD) 22.6 (6.8) 24.7 (6.1) 24.3 (4.9) 24.5 (5.3) 0.24* NS
QOL-AD total Mean (SD) 32.1 (6.9) 27.2 (6.7) 35.3 (4.9) 35.6 (4.9) # #
Notes: *One-way ANOVA followed by post-hoc Tukey’s test if appropriate.
#Repeated measures ANOVA, globally MCI patients had lower QOL-AD scores than controls (p5 0.001), there was a
significant difference between the subjects’ own report and their informants’ report in MCI patients (p¼ 0.007), see text. NS: not
statistically significant; MCI-I: MCI patient informant; C: Control subject; C-I: Control subject informant.
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applied to both the patient and the informant that
assesses positive affect, negative affect, feelings of
belonging, self-esteem, and sense of aesthetics, which
are quite distinct from the concrete domains addressed
in the QOL-AD scale (Table 3). The other study used
the Alzheimer’s Disease related QoL (Rabins, Kasper,
Kleinman, Black, & Patrick, 1999), which reflects
caregiver judgments about the patient’s social interac-
tion, awareness of self, feelings and mood, enjoyment
of activities, and response to surroundings; and since it
tackles rather basic behaviors of the patient, it may not
be sensitive to early phases of cognitive decline. Still
another study found in patients with MCI differences
in one domain, psychological QoL, but not in other
domains or in total score of the self-reported World
Health Organization QoL scale (Muangpaisan et al.,
2008).
The present study, using the QOL-AD scale, which
allows appraisal of QoL in patients with cognitive
decline both from the patient and the informant points
of view, clearly shows that patients with MCI have a
decrease in their QoL. This decrease involved several
respects of QoL beyond cognition, namely social
relationships, ability to enjoy himself/herself and
mood. Although MCI patients had slightly higher
scores on Charlson comorbidities index than control
subjects, both groups scored at the same level of
comorbidity, so this factor would not explain the
difference of QOL-AD between MCI patients and
controls.
An interesting finding of the present study is that
the QoL reported by patients with MCI was more
favorable than the opinion of their informants,
whereas the reports of healthy controls and their
informants were concordant. The tendency for infor-
mants to rate QoL lower than patients is consistent
with what is observed in more advanced stages of
cognitive decline, that is, dementia or Alzheimer’s
disease (Conde-Sala et al., 2009; Hurt et al., 2008;
Ready et al., 2004; Thorgrimsen et al., 2003; Vogel
et al., 2006). Although the MCI patients had more
depressive symptoms, reflected by higher GDS scores,
and previous studies have found a higher prevalence of
depressive symptoms in patients with MCI (Solfrizzi
et al., 2007), the presence of depressive symptoms
could not explain the observed difference in the QoL
reported by patients with MCI and their informants,
since they would tend to worsen their perception of
QoL, just the opposite of what was observed. On the
other hand, their informants, who were also often their
caregivers, were not more depressed than the healthy
controls or their informants, thus ruling out that
caregivers’ depression would explain a more negative
opinion about their patients’ QoL. However, the
possibility that informants, by being aware of the
clinical status and memory complains of their patients,
could overestimate small deficits cannot be excluded.
The finding that the QoL reported by patients with
MCI was better than the opinion of their informants is
probably better explained by MCI patients being less
aware of their cognitive and functional decline. In fact,
some degree of anosognosia was previously described
in patients with MCI (Galeone, Pappalardo, Chieffi,
Iavarone, & Carlomagno, 2011). However, it should be
noted that when scores in individual QOL-AD items
were compared between MCI patients and their
informants, the item ‘Memory’ showed no statistical
difference, which suggests that patients with MCI were
quite aware of their cognitive difficulties. On the other
hand, patient scores were significantly higher for the
item ‘Ability to do chores around the house’, which
may reveal lack of insight about the functional decline.
Differences in individual QOL-AD items may reflect
not only distinct perceptions but also different expec-
tations from the MCI patients and their informants
(Carr, Gibson, & Robinson, 2001).
A few comments about the characterization of the
MCI patients recruited in the present study are
worthwhile. Although the MMSE scores in MCI
patients were within the normal range, they were
significantly lower than in the other groups, as found
in previous studies (see, for instance, Nunes et al.,
2010). The decrease in QoL found in MCI patients
with QOL-AD was not paralleled by a corresponding
decrease in satisfaction with life, as measured with the
SWLS scale. This finding strengthens the idea that
these instruments address distinct constructs.
Limitations of the present study must be recog-
nized, in particular, the sample used for MCI group in
this study consisted mainly of patients from a memory
clinic, and the results may not be extended to general
population.
In conclusion, the QoL was decreased in MCI
patients as compared to controls without cognitive
impairment. The QoL reported by patients with MCI
was better than the opinion of their informants. QoL
appears to be an important domain to be evaluated in
studies in MCI, and possibly an interesting outcome
measure for therapeutic interventions.
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